Evidence map›Paper›PMID 12695302›Full record

ArticleCirculation2003

Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription.

Chu-Huang Chen, Tao Jiang, Jun-Hai Yang, Wei Jiang, Jonathan Lu, Gopal K Marathe, Henry J Pownall, Christie M Ballantyne, Thomas M McIntyre, Philip D Henry and 1 more

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Circulation, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00988364 (Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 in Patients With Metabolic Syndrome), which is not on this map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00988364 phase4completedstarted 2007, after this paper: background citation

Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 in Patients With Metabolic Syndrome

Ran2007Enrolled30Registered outcomes2Posted comparisons0ConditionsMetabolic SyndromeArmsEzetimibe, Placebo, simvastatin, Vytorin
Open the trial in the graph
3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 155 citations in OpenAlex.

  1. Article
  2. Review
  3. Very low-density lipoprotein and the human health.World journal of experimental medicine · 2026
    Review
  4. Cellular basis of HFpEF: contributions of abnormal lipids.Frontiers in cardiovascular medicine · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Chu-Huang ChenMS A-601, Department of Medicine, Baylor College of Medicine, 6565 Fannin St, Houston, Texas 77030, USA. cchen@bcm.tmc.edu
Tao Jiang
Jun-Hai Yang
Wei Jiang
Jonathan Lu
Gopal K Marathe
Henry J Pownall
Christie M Ballantyne
Thomas M McIntyre
Philip D Henry
Chao-Yuh Yang
Mahindra and Mahindra Limited (India) · IN

Funding

BIOLOGICAL ACTIVITYP OF OXIDIZED PHOSPHOLIPIDSR01HL044513 · NHLBI · UNIVERSITY OF UTAH · PI MCINTYRE, THOMAS M · 1990 to 2008
$3.0M
ENZYMIC REACTIONS OF MODEL PLASMA LIPOPROTEINSR01HL030914 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI POWNALL, HENRY J. · 1985 to 2010
$2.2M
Oxidation of Apolipoprotein B-100 in LDLR01HL063364 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI YANG, CHAO-YUH · 2001 to 2004
$1.2M
NHLBI NIH HHS HL-30914NHLBI NIH HHS HL-44513NHLBI NIH HHS HL-63364
6 · The paper itself

Abstract

backgroundApoptosis of vascular endothelial cells (ECs) can be induced in vitro by experimentally modified LDL. Description of proapoptotic circulating lipoproteins may significantly enhance understanding of atherothrombosis pathophysiology. METHODS AND

resultsFast protein liquid chromatography of LDL samples from 7 asymptomatic, hypercholesterolemic patients yielded subfractions L1-L5 in increasing electronegativity. L4 and L5 were not detectable or collectible in normolipidemic samples. In bovine aortic EC cultures, L5 induced marked apoptosis and L4 had a mild effect, whereas hypercholesterolemic or normolipidemic L1-L3 had negligible effects. Compared with copper-oxidized LDL, L5 was only mildly oxidized, although its propensity to form conjugated dienes in response to copper exceeded that of other subfractions. L5-induced apoptosis was associated with suppressed fibroblast growth factor 2 (FGF-2) transcription, as assessed by nuclear run-on analysis. Degrading platelet-activating factor (PAF)-like lipids in L5 by a recombinant PAF acetylhydrolase prevented both FGF-2 downregulation and apoptosis. Furthermore, the ability of L5 lipid extract to induce calcium influx into neutrophils was lost after pretreatment of the extract with PAF acetylhydrolase. FGF-2 supplementation, PAF receptor (PAFR) blockade with WEB-2086, and inactivation of PAFR-coupled Gi protein with pertussis toxin all effectively attenuated L5-induced apoptosis.

conclusionsOur findings indicate that a highly electronegative, mildly oxidized LDL subfraction present in human hypercholesterolemic but not normolipidemic plasma can induce apoptosis in cultured ECs. The evidence that a freshly isolated LDL species modulates transcription of FGF-2 may provide a physiological insight into the mechanism of vascular EC apoptosis in hypercholesterolemia.

Indexed as

ApoptosisAdultAnimalsCalciumCattleCells, CulturedChemical FractionationEndothelium, VascularFemaleFibroblast Growth Factor 2Gene Expression RegulationHumansHypercholesterolemiaIon TransportLipoproteins, LDLMaleCalciumFibroblast Growth Factor 2Lipoproteins, LDL

Identifiers

PMID12695302
OpenAlexW2140815756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.